FDA Approved: FLUVOXAMINE MALEATE — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a generic fluvoxamine maleate product (Actavis Pharma) under Original Application (ANDA). The indication is obsessive-compulsive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Fluvoxamine Maleate (Fluvoxamine maleate)

Snippet

ORIG AP for FLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE)